Michael Taylor
Vermögen: - $ am 31.08.2026
Vermögen: - $ am 31.08.2026
Mr. Michael Taylor is an Independent Director at NRX Pharmaceuticals, Inc. He is on the Board of Directors at NRX Pharmaceuticals, Inc. Mr. Taylor was previously employed as a Partner by Adi Dassler International Family Office LLC, a Managing Director by Oppenheimer & Co., Inc., and a MD-Institutional Fixed Income Trading by Stone & Youngberg LLC.
He received his undergraduate degree from London School of Economics & Political Science.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.02.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NRX PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 15.01.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
Adi Dassler International Family Office LLC | Corporate Officer/Principal | 14.02.2023 |
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Corporate Officer/Principal | 01.08.2016 |
Stone & Youngberg LLC
Stone & Youngberg LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.06.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Finance |
Stone & Youngberg LLC
Stone & Youngberg LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
London School of Economics & Political Science
London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adi Dassler International Family Office LLC | |
NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a molecule pharmaceutical company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen